Villy Valcheva
Directeur Technique/Scientifique/R&D chez GH RESEARCH PLC
Profil
Velichka Valcheva is currently working as the Chief Medical Officer at GH Research Plc.
Previously, she worked as the VP & Head-International Medical Affairs at Albireo Pharma, Inc. She holds a doctorate degree from the Medical University of Plovdiv and a graduate degree from Trinity College Dublin.
Postes actifs de Villy Valcheva
| Sociétés | Poste | Début |
|---|---|---|
| GH RESEARCH PLC | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Villy Valcheva
| Sociétés | Poste | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | - |
Formation de Villy Valcheva
| Trinity College Dublin | Graduate Degree |
| Medical University of Plovdiv | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
